Circulating Tumor DNA Testing for Liver Cancer

Circulating Tumor DNA Testing for Liver Cancer

Bibliographic Details
Main Authors:	Larissa V. Furtado, Jeremy P. Segal
Format:	Article
Language:	English
Published:	Elsevier 2015-09-01
Series:	Cellular and Molecular Gastroenterology and Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352345X15001265

Similar Items

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
by: Alistair Rice, et al.
Published: (2019-09-01)

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
by: Yasunori Uesato, et al.
Published: (2020-01-01)

Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
by: Aixa E. Soyano, et al.
Published: (2019-02-01)

Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid BiopsySummary
by: Atsushi Ono, et al.
Published: (2015-09-01)

Circulating tumor DNA for personalized lung cancer monitoring
by: Clare Fiala, et al.
Published: (2017-08-01)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
by: Chen Q, et al.
Published: (2019-12-01)

Circulating tumor DNA as a marker of residual tumor in colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2018-11-01)

Cell-free circulating tumor DNA in cancer
by: Zhen Qin, et al.
Published: (2016-04-01)

Circulating Tumor DNA as Biomarkers for Cancer Detection
by: Xiao Han, et al.
Published: (2017-04-01)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
by: Hariti Saluja, et al.
Published: (2018-07-01)

Future perspectives of circulating tumor DNA in colorectal cancer
by: C Nadal, et al.
Published: (2017-05-01)

The role of circulating tumor DNA in patients with colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2016-10-01)

Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
by: Wei Zhang, et al.
Published: (2017-02-01)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
by: Ming Yu, et al.
Published: (2021-01-01)

The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA
by: Tenna V. Henriksen, et al.
Published: (2020-08-01)

Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
by: Marta Tellez-Gabriel, et al.
Published: (2020-12-01)

Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA
by: Michael J Duffy, et al.
Published: (2018-05-01)

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
by: Clare Fiala, et al.
Published: (2018-10-01)

Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management
by: Alessandra Sacco, et al.
Published: (2020-10-01)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
by: Isabel Heidrich, et al.
Published: (2021-09-01)

The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
by: Mira Shoukry, et al.
Published: (2021-07-01)

Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic
by: Alessia Cimadamore, et al.
Published: (2021-05-01)

Fragment Length of Circulating Tumor DNA.
by: Hunter R Underhill, et al.
Published: (2016-07-01)

Genome‐wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis
by: Tao Wei, et al.
Published: (2020-09-01)

Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients
by: Lindsey M. Charo, et al.
Published: (2021-01-01)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Qianwei Ye, et al.
Published: (2019-07-01)

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
by: Yidong Zhou, et al.
Published: (2019-05-01)

Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer
by: Tommaso Grassi, et al.
Published: (2021-01-01)

Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer.
by: Tommaso Grassi, et al.
Published: (2021-01-01)

Characterization of DNA Methylation in Circulating Tumor Cells
by: Constantin F. Pixberg, et al.
Published: (2015-10-01)

Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
by: Jacob J. Adashek, et al.
Published: (2021-07-01)

Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
by: Miles W. Grunvald, et al.
Published: (2020-10-01)

Utility of Circulating Tumor DNA in Different Clinical Scenarios of Breast Cancer
by: Alexandra Mesquita, et al.
Published: (2020-12-01)

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer
by: Hitendra Patel, et al.
Published: (2019-12-01)

Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer
by: Bianca C. T. Flores, et al.
Published: (2021-08-01)

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis
by: He Y, et al.
Published: (2020-03-01)

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
by: Susan M. Mitchell, et al.
Published: (2016-12-01)

Liquid Biopsy in 2017: Circulating Tumor Cells and Circulating Tumor DNA in Precision Medicine
by: Lei CAI, et al.
Published: (2017-03-01)

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
by: Qiaomei Guo, et al.
Published: (2018-08-01)